Tocilizumab for Patients With Giant Cell Arteritis

NCT01450137 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Giant Cell Arteritis

Interventions

DRUG: Tocilizumab + Glucocorticoids (GCs)
DRUG: Placebo + Glucocorticoids (GCs)

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators

[object Object]
[object Object]